-
Mashup Score: 0A Reason to Retire? | NEJM - 8 month(s) ago
Perspective from The New England Journal of Medicine — A Reason to Retire?
Source: www.nejm.orgCategories: Latest Headlines, Oncologists1Tweet
-
Mashup Score: 2River - 8 month(s) ago
Sorry, the page you were looking for could not be found. Please check the address and try again, or take a look at the site map. If you have any further problems please get in touch.
Source: www.cclg.org.ukCategories: Latest Headlines, Oncologists1Tweet-
A most excellent session on renal tumours of childhood #SIOP2023 #SIOPcongress Please do join us for an excellent educational programme on state of the art treatment for paediatric renal tumours organised for @CCLG_UK by @MarkGaze https://t.co/UUk68RGoui…
-
-
Mashup Score: 0
Triple Negative Breast Cancer (TNBC) is an aggressive form of cancer with high rates of recurrence. Despite incredible strides made to lower breast cancer mortality in the U.S., the risk of death for women diagnosed with TNBC is far greater than for those diagnosed other types of breast cancer. Please join us for this pertinent panel discussion.
Source: events.r20.constantcontact.comCategories: Latest Headlines, Oncologists1Tweet-
Join us for the NMQF Webinar as we discuss Triple Negative Breast Cancer w/ @MeliD32 @touchbbca https://t.co/mxl2UN2SmF
-
-
Mashup Score: 1Speeding up Antibody-Drug Conjugate Development in Pretreated EGFR-Mutant Non–Small-Cell Lung Cancer - 8 month(s) ago
The treatment landscape of epidermal growth factor receptor (EGFR)–mutant advanced NSCLC has rapidly evolved. Third-generation tyrosine kinase inhibitors (TKIs) are now the preferred standard treatment option in the first-line setting 1 on the b asis of prolonged progression-free survival (PFS) and superior intracranial activity when compared with first-generation epidermal growth factor receptor (EGFR) TKIs. 2 – 7 Unfortunately, resistance inevitably develops. Although several mechanisms of acquired
Source: ascopubs.orgCategories: Latest Headlines, Oncologists1Tweet-
Speeding up Antibody-Drug Conjugate Development in Pretreated EGFR-Mutant Non–Small-Cell Lung Cancer by @JordiRemon and Lizza Hendriks https://t.co/cbL4QqR63s
-
-
Mashup Score: 1Younger Women Are Getting Lung Cancer at Higher Rates Than Men - 8 month(s) ago
Researchers are struggling to understand what is driving the gender disparity in lung cancer cases among people 35 to 54.
Source: www.nytimes.comCategories: Latest Headlines, Oncologists1Tweet-
Women between the ages of 35 and 54 are being diagnosed with #LungCancer at higher rates than men in that same age group, according to a report published Thursday by researchers at the American Cancer Society. #LCSM https://t.co/lyPsaDa3Xv
-
-
Mashup Score: 0Patient hails new UW Health dry mouth treatment a 'game-changer' - 8 month(s) ago
Dry mouth can cause dental and salivary gland concerns.
Source: spectrumnews1.comCategories: Latest Headlines, Oncologists1Tweet-
Congrats to @KimpleRandall @UW_RadoncDHO and @JacquesGalipeau @uw_hemeoncpc on manufacturing IFNg-licensed #MSCs as cell therapy for relieving dry mouth after radiation therapy in #headandneckcancer patients @UWCarbone @UWSCRMC https://t.co/qkIQiLqx8B
-
-
Mashup Score: 2
MADISON, WIS. (CBS 58) — If you own enough dogs over time, chances are high that at least one of them will die from cancer. It is the number one killer of senior dogs. Scientists at UW-Madison are st
Source: www.cbs58.comCategories: Latest Headlines, Oncologists1Tweet-
Excited to see David Vail @uwvetmed @UWCarbone lead the VACCS multi-center trial as a site PI with @ColoradoStateU @ucdavisvetmed on using the first preventative vaccine for #cancer in companion dogs #immunotherapy https://t.co/DKZQ9DhjaA
-
-
Mashup Score: 2What scientific idea is ready for retirement? - 8 month(s) ago
Each year edge.org, an internet forum for the world’s most brilliant minds, asks one question. This year’s drew responses from Richard Dawkins, Ian McEwan and Alan Alda
Source: www.theguardian.comCategories: Latest Headlines, Oncologists1Tweet-
The mouse is the real Elephant in cancer research: https://t.co/lLh76yGEy6
-
-
Mashup Score: 1Metabolomic Differences: Young Onset (yoCRC) vs. Average Onset (aoCRC) Colorectal Cancer - 8 month(s) ago
Listen as Dr. Kamath talks about the challenges associated with early detection, the evolving landscape of screening guidelines, potential contributing factors to the rise of yoCRC, and the role of metabolomics in unraveling the complexities of colorectal cancer.
Source: my.clevelandclinic.orgCategories: Latest Headlines, Oncologists1Tweet-
RT @jamecancerdoc: Metabolomic Differences: Young Onset (yoCRC) vs. Average Onset (aoCRC) Colorectal Cancer https://t.co/ZywmdZQHDY via @cl…
-
-
Mashup Score: 5Younger Women Are Getting Lung Cancer at Higher Rates Than Men - 8 month(s) ago
Researchers are struggling to understand what is driving the gender disparity in lung cancer cases among people 35 to 54.
Source: www.nytimes.comCategories: Latest Headlines, Oncologists1Tweet-
🫁🧬 “I have women that have come with chest pressure and leave the office with Xanax…And then when they start coughing up blood, that’s when somebody listens to them.” Proud of Dr @NarjustFlorezMD’s advocacy for young women with #lungcancer #lcsm https://t.co/aRlnafUM9y
-
ICYMI: “My patients’ illnesses are starting to get to me." https://t.co/qmJQNucntQ